Company
Alaunos Therapeutics, Inc.
TCRT · CIK 0001107421
Acquisition (code A) of 21,829 shares at $0.7444 per share.
Reporting Person Postma Robert W · Transaction Code A
Traded Oct 6, 2026 · Disclosed Oct 8, 2026
Source: SEC Form 4 · 0001193125-26-417969 · filed 2026-10-08 · View filing →
Acquisition (code A) of 23,564 shares at $0.7444 per share.
Reporting Person Weis Holger · Officer Title CEO · Transaction Code A
Traded Oct 6, 2026 · Disclosed Oct 8, 2026
Source: SEC Form 4 · 0001193125-26-417970 · filed 2026-10-08 · View filing →
Acquisition (code A) of 22,669 shares at $0.7444 per share.
Reporting Person Vieser Jaime · Transaction Code A
Traded Oct 6, 2026 · Disclosed Oct 8, 2026
Source: SEC Form 4 · 0001193125-26-417971 · filed 2026-10-08 · View filing →
Acquisition (code A) of 20,990 shares at $0.7444 per share.
Reporting Person Jerman Michael Allen · Transaction Code A
Traded Oct 6, 2026 · Disclosed Oct 8, 2026
Source: SEC Form 4 · 0001193125-26-417974 · filed 2026-10-08 · View filing →